Mesoblast Limited (NASDAQ:MESO) Q1 2023 Earnings Call Transcript

Mesoblast Limited (NASDAQ:MESO) Q1 2023 Earnings Call Transcript November 23, 2022

Dr. Silviu Itescu: Good morning, good afternoon to the operational highlights and financial results for the quarter ended September 30, 2022, as well as our upcoming Annual General Meeting. Apologies for the slight delay due to technical difficulties; beyond our control. Joining me here today is Dr. Eric Rose, our Chief Medical Officer; and Andrew Chaponnel, our Interim Chief Financial Officer. If we could go...